Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

AHK-Cu and CJC-1295 (without DAC) Interaction: Synergistic | Peptide Database

Can you take AHK-Cu with CJC-1295 (without DAC)? Synergistic interaction (47% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

AHK-Cu

Hair Growth Copper Peptide | Dermal Papilla Stimulator

AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood flow, reduces TGF-β1, and promotes SOD production for oxidative stress reduction.

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Combined Organ Load

Frequently Asked Questions

Can I take AHK-Cu with CJC-1295 (without DAC)?

Yes, AHK-Cu and CJC-1295 (without DAC) can generally be taken together. AHK-Cu and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is AHK-Cu and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between AHK-Cu and CJC-1295 (without DAC)?

AHK-Cu and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time AHK-Cu and CJC-1295 (without DAC)?

AHK-Cu has a half-life of Not established and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question